1. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging
- Author
-
S K Ternovoi, A G Pistrak, A. G. Mazhuga, Maxim A. Abakumov, B Ya Myshkinis, M. V. Konstantinov, Vladimir P. Chekhonin, D M Dmitriev, and E. I. Demikhov
- Subjects
0301 basic medicine ,Materials science ,media_common.quotation_subject ,Iron oxide ,Contrast Media ,Ferric Compounds ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Nuclear magnetic resonance ,Cell Line, Tumor ,medicine ,Animals ,Contrast (vision) ,Magnetite Nanoparticles ,media_common ,medicine.diagnostic_test ,Brain ,Magnetic resonance imaging ,General Medicine ,Rat brain ,medicine.disease ,Magnetic Resonance Imaging ,eye diseases ,Rats ,030104 developmental biology ,chemistry ,Magnetic nanoparticles ,Glioblastoma ,human activities ,030217 neurology & neurosurgery ,Iron oxide nanoparticles - Abstract
Magnetic resonance imaging (MRI) is one of the most perspective methods of noninvasive visualization in medicine, and use of contrast agents significantly its potentialities extends. Iron oxide nanoparticles are promising contrast agents, but in fact all the data on their efficiency were obtained in high-field tomographs for experimental animals. We studied the possibility of using magnetic nanoparticles for MRI visualization of rat brain glioblastoma at the most common clinical field 1.5 T The data indicate the efficiency of iron oxide magnetic nanoparticles as contrast agents for 1.5 T MR tomographs.
- Published
- 2019
- Full Text
- View/download PDF